Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Removed MedlinePlus Genetics topic on Melanoma, narrowing the page's coverage of genetics topics related to melanoma.
    Difference
    0.2%
    Check dated 2025-10-20T13:30:27.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    3%
    Check dated 2025-10-06T05:19:44.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Melanoma. No deletions observed.
    Difference
    0.2%
    Check dated 2025-09-21T22:34:47.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Updated to v3.0.2. Removes the Melanoma topic under MedlinePlus Genetics (a core content item) and removes the Back to Top link along with the older v3.0.1 reference.
    Difference
    0.4%
    Check dated 2025-09-14T18:59:12.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T14:15:17.000Z thumbnail image

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.